Geneva Capital Management’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-197,307
Closed -$3.11M 125
2022
Q3
$3.11M Sell
197,307
-143,179
-42% -$3.22M 0.07% 115
2022
Q2
$8.59M Buy
340,486
+1,589
+0.5% +$47.5K 0.2% 95
2022
Q1
$12.2M Sell
338,897
-336,502
-50% -$16.6M 0.24% 98
2021
Q4
$51.8M Buy
675,399
+97,722
+17% +$8.62M 0.83% 49
2021
Q3
$55.5M Buy
577,677
+119,022
+26% +$13M 0.94% 40
2021
Q2
$48.9M Sell
458,655
-7,661
-2% -$754K 0.8% 55
2021
Q1
$41.8M Sell
466,316
-10,907
-2% -$1.2M 0.71% 62
2020
Q4
$48M Buy
477,223
+14,470
+3% +$1.08M 0.81% 51
2020
Q3
$22.6M Buy
+462,753
New +$22.2M 0.47% 83

Other funds holding CRNC

Geneva Capital Management's CRNC Position: Q4 2022 in Review

Geneva Capital Management sold out of Cerence (CRNC) in Q4 2022, closing a stake of 197,307 shares — an estimated $3.11M sold.

Geneva Capital Management first reported a position in CRNC in Q3 2020 and held it in 9 quarters. The position peaked at $55.5M in Q3 2021. 223 funds tracked by Wall St. Rank hold CRNC as of Q4 2022.

  • Geneva Capital Management reported no remaining Cerence position as of Q4 2022 after selling out during the quarter.
  • Geneva Capital Management sold 197,307 Cerence shares in Q4 2022, an estimated $3.11M.
  • Geneva Capital Management first reported a position in Cerence in Q3 2020 and held it in 9 quarters.
  • Geneva Capital Management's Cerence position peaked at $55.5M in Q3 2021.
  • 223 funds tracked by Wall St. Rank held Cerence as of Q4 2022.

Based on Geneva Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.